Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL1137637

NC(=O)C(C(=O)Nc1cc(F)c(Oc2ccnc(N)c2)cc1F)C(C(N)=O)c1ccccc1.O=C(O)C(F)(F)F

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ MET P08581 12/20 0.41
▸ BRAF P15056 5/20 0.39
▸ MAPK14 Q16539 2/20 0.39
▸ NTRK1 P04629 1/20 0.35
▸ KDR P35968 1/20 0.35
▸ TEK Q02763 1/20 0.35
▸ NTRK3 Q16288 1/20 0.35
▸ NTRK2 Q16620 1/20 0.35
▸ ALOX5AP P20292 1/20 0.35
▸ FEN1 P39748 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1137671 0.96 MET (0.43) METBRAFMAPK14NTRK1KDR
SCHEMBL1137269 0.84 MET (0.44) METBRAFMAPK14NTRK1KDR
SCHEMBL1137252 0.83 MET (0.57) METBRAFKDR
Trifluoroacetic Acid SCHEMBL1137638 0.82 MET (0.48) METBRAFMAPK14NTRK1KDR
Trifluoroacetic Acid SCHEMBL3013148 0.82 MET (0.48) METBRAFMAPK14NTRK1KDR
SCHEMBL1137672 0.77 MET (0.52) METBRAFMAPK14NTRK1KDR
SCHEMBL3003006 0.77 MET (0.52) METBRAFMAPK14NTRK1KDR
Trifluoroacetic Acid SCHEMBL3013150 0.75 MET (0.40) METMAPK14ALOX5APFEN1
SCHEMBL1137217 0.74 MET (0.52) METBRAFMAPK14
SCHEMBL1137271 0.73 MET (0.51) METBRAFMAPK14NTRK1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989477-B2 Monocyclic heterocycles as kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2011-08-02 — — US disclosed
EP-1737451-B1 MONOCYCLIC HETEROCYCLES AS KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2011-02-23 — — EP disclosed
Send feedback